This page contains documents relating specifically to the Pfizer BioNTech COVID-19 and Comirnaty® vaccine.
National protocol for Comirnaty® COVID-19 mRNA vaccine
National protocol for Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine
National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) (withdrawn on 20 April 2022)
Pfizer BioNTech COVID-19 vaccine information
Gov.uk - Regulatory approval of COVID-19 Pfizer BioNTech vaccine | Regulatory approval of COVID-19 Pfizer BioNTech vaccine |
Comirnaty® vaccine Patient Information Leaflet | |
Comirnaty® vaccine SPC |
COVID-19: vaccine Comirnaty® 'SPC' COVID-19: vaccine Comirnaty® (10micrograms/dose) concentrate 'SPC' Children 5 to 11 |
Pfizer BioNTech vaccine SPC | |
Patient Group Direction for Comirnaty® |
Patient Group Direction for Comirnaty® (Pfizer BioNTech) Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years |
Patient Specific Direction Pfizer vaccine (for local adoption) | |
Pfizer BioNTech vaccine Patient Information Leaflet |
COVID-19: vaccine BNT162b2 Patient Information Leaflet |
Pfizer Vaccine Ingredients | |
British Islamic Medical Association statement |
British Islamic Medical Association: Position statement on the Pfizer/BioNTech COVID-19 vaccine |
SPS Pfizer-BioNTech information